This inventor holds 1 USPTO granted patent. Top assignee: Kali-Chemie Pharma Gmbh. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Patrick Lenoir: Innovator in Pharmacologically Active Compounds
Introduction
Patrick Lenoir is a notable inventor based in Romans, France. He has made significant contributions to the field of pharmacology through his innovative work on active compounds. His research focuses on developing new chemical entities that can have therapeutic applications.
Latest Patents
Lenoir holds a patent for "5-phenylpyrrolo-1,4-benzoxazine and 5-phenylpyrrolo-1,4-benzothiazine," which are pharmacologically active compounds. This patent includes compounds of formula I, which can be substituted in the phenyl rings, with R¹ denoting hydrogen or lower alkyl. This innovation represents a step forward in the development of new medications.
Career Highlights
Patrick Lenoir is currently associated with Kali-Chemie Pharma GmbH, where he continues to advance his research in pharmacology. His work has been instrumental in exploring new therapeutic avenues and enhancing the understanding of chemical compounds.
Collaborations
Lenoir collaborates with fellow researcher Patrice Demonchaux, contributing to the advancement of their shared goals in pharmacological research.
Conclusion
Patrick Lenoir's contributions to the field of pharmacology through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for new therapeutic possibilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile